US Patent 12065478 HER2-targeting antigen binding molecules comprising 4-1BBL
Patent 12065478 was granted and assigned to Hoffmann-La Roche Limited on August, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+37 properties)
Article (+350 characters)
US Patent 12065478 HER2-targeting antigen binding molecules comprising 4-1BBL
Article
Patent abstract
The invention relates to Her2 targeting 4-1BB agonists, in particular 4-1BBL trimer-containing antigen binding molecules comprising at least one antigen binding domain capable of specific binding to Her2 and their use in the treatment of cancer as well as their use in combination with T-cell activating anti-CD3 bispecific antibodies.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Christian Klein0
Christina Claus0
Claudia Ferrara Koller0
Pablo Umana0
Teemu Tapani Junttila0
Date of Patent
August 20, 2024
0Patent Application Number
170667110
Date Filed
October 9, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12065478 HER2-targeting antigen binding molecules comprising 4-1BBL
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
